Search Tag: anti-viral drugs

Cardiology Management

2021 04 Nov

U.K.’s Medicines and Healthcare Products Regulatory Agency has authorised the first oral antiviral medicine for treating mild-to-moderate COVID-19 in adults with a positive COVID-19 infection and at least one risk factor for developing severe illness.    Molnupiravir will be the first oral medicine authorised for COVID-19. This is a major achievement...Read more

ICU Management

2021 16 Feb

Mortality trials of four antiviral drugs - remdesivir, hydroxychloroquine, lopinavir and interferon beta-1a were recommended by the World Health Organization (WHO) to evaluate their effect in patients hospitalised with COVID-19. In March 2020, the WHO began a large international trial that included hospital inpatients to evaluate the effects...Read more